These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12421685)

  • 1. The possible role of complement activation in Alzheimer disease.
    McGeer PL; McGeer EG
    Trends Mol Med; 2002 Nov; 8(11):519-23. PubMed ID: 12421685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmune mechanisms in Alzheimer disease pathogenesis.
    McGeer PL; Rogers J; McGeer EG
    Alzheimer Dis Assoc Disord; 1994; 8(3):149-58. PubMed ID: 7986484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
    McGeer PL; McGeer EG
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S1-6. PubMed ID: 9769023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New opportunities in AD research--roles of immunoinflammatory responses and glia.
    Frederickson RD; Brunden KK
    Alzheimer Dis Assoc Disord; 1994; 8(3):159-65. PubMed ID: 7986485
    [No Abstract]   [Full Text] [Related]  

  • 5. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
    Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
    Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
    Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological proteins in senile plaques.
    McGeer PL; Klegeris A; Walker DG; Yasuhara O; McGeer EG
    Tohoku J Exp Med; 1994 Nov; 174(3):269-77. PubMed ID: 7761992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of complement in Alzheimer's disease pathology.
    Emmerling MR; Watson MD; Raby CA; Spiegel K
    Biochim Biophys Acta; 2000 Jul; 1502(1):158-71. PubMed ID: 10899441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
    McGeer PL; Rogers J; McGeer EG
    J Alzheimers Dis; 2006; 9(3 Suppl):271-6. PubMed ID: 16914866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    McGeer PL; Rogers J; McGeer EG
    J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
    McGeer PL
    Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
    Lim GP; Yang F; Chu T; Chen P; Beech W; Teter B; Tran T; Ubeda O; Ashe KH; Frautschy SA; Cole GM
    J Neurosci; 2000 Aug; 20(15):5709-14. PubMed ID: 10908610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.
    Eikelenboom P; Veerhuis R
    Neurobiol Aging; 1996; 17(5):673-80. PubMed ID: 8892339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
    Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
    Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.